2022
Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake
Oles W, Alexander M, Kumar N, Howell B, O’Connor P, Madden LM, Barry DT. Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake. BMC Psychiatry 2022, 22: 236. PMID: 35366844, PMCID: PMC8976510, DOI: 10.1186/s12888-022-03884-5.Peer-Reviewed Original ResearchConceptsLow-threshold clinicDemographic characteristicsOpioid use disorder treatmentMultivariate logistic regression modelBrief Pain InventoryPatient demographic characteristicsOpioid use disorderSocial supportSymptom Identification ScaleUse disorder treatmentNon-Hispanic whitesLogistic regression modelsOlder patientsPain InventoryTreatment cohortsSelf-reported social supportLife Events ChecklistMOUD treatmentBaseline disparitiesTreatment accessTreatment needsHigh riskUse disordersMortality rateDisorder treatment
2021
Chapter 9 Outpatient opioid use disorder treatment for the ID physician
Muthulingam D, Madden L, Altice F. Chapter 9 Outpatient opioid use disorder treatment for the ID physician. 2021, 161-187. DOI: 10.1016/b978-0-323-68328-9.00009-6.Peer-Reviewed Original ResearchOpioid use disorderOUD treatmentOpioid use disorder treatmentExtended-release naltrexoneInfectious disease cliniciansInitiation of treatmentSpecial clinical considerationsUse disorder treatmentHIV practiceID cliniciansOUD pharmacotherapyIntegrated care deliveryID physiciansMedication optionsOpioid epidemicTreatment expansionTreatment accessUse disordersAddiction specialistsClinical considerationsOUD managementDisorder treatmentGeneral IDCare deliveryPractice settings